S100B and cerebral palsy: It can be used for diagnosis and evaluation of neuropsychiatric diseases such as schizophrenia, mood disorders, cerebral palsy and traumatic brain injury.[27,28] This study retrospectively analyzed serum S100B protein expression in 46 patients in the CwG group and compared the results to those of 35 patients in FS group.